We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 1,227

Africa update - November 6, 2014
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • Africa, European Union, Global, USA
  • November 6 2014

On October 29th, the U.S. Agency for International Development (USAID) issued a new fact sheet on the Ebola outbreak. The fact sheet highlighted the

International news: focus on compliance - winter 2014
  • McDermott Will & Emery
  • China, European Union, Germany, Global, USA
  • December 2 2014

As regulatory oversight of companiesfrom Sarbanes Oxley and the Dodd-Frank Act to the Foreign Corrupt Practices Act (FCPA) and the UK Bribery

US and European approaches to antibody patents
  • FB Rice
  • European Union, USA
  • June 13 2013

When monoclonal antibodies were first produced in 1974, Kohler and Milstein predicted that they “could be valuable for medical and industrial use”

Food, dietary supplement & cosmetics regulatory update, volume II, issue 12
  • Jones Day
  • European Union, USA
  • June 11 2015

FDA issued a final rule last week, called the Veterinary Feed Directive ("VFD"), that reduces the amount of antibiotics used in animal production. As

Privacy & cybersecurity update, issue 3 - October, 2014
  • Jones Day
  • Australia, Brazil, Canada, Russia, Taiwan, USA, Ireland, Italy, Japan, Mexico, Netherlands, New Zealand, Chile, China, European Union, France, Germany, Hong Kong
  • October 15 2014

On August 1, the Federal Trade Commission ("FTC") issued a report on mobile shopping applications. In it, the FTC found that such apps often fail to

Kartellrechtliche fallstricke im life science-bereich
  • Baker & McKenzie
  • European Union, France, USA
  • May 24 2013

Im Wettbewerb gegen Generika ist Vorsicht geboten: Verschiedene Maßnahmen gegen den Markteintritt kostengünstigerer Generika werden

Measure - Summer 2013
  • King & Spalding LLP
  • European Union, Middle East, Saudi Arabia, United Arab Emirates, USA
  • July 3 2013

This issue is rich in news on emerging market trends and legal developments. A revival in real estate investments has been witnessed across the globe

Unlocking the Promise of Personalized Medicine: Reimbursement, Coverage, and Clinical Utility
  • Foley & Lardner LLP
  • European Union, USA
  • September 15 2014

AmerisourceBergen, in connection with the Business of Personalized Medicine Summit, released "Unlocking the Promise of Personalized Medicine:

European markets less than enthusiastic over biosimilars
  • Shook Hardy & Bacon LLP
  • European Union, USA
  • December 12 2013

While Europe has had a regulatory approval pathway for biosimilar drug products for some years, their use reportedly remains anemic. Physicians are

Global corporate insurance & regulatory bulletin
  • Mayer Brown JSM
  • China, European Union, United Kingdom, USA
  • December 5 2013

The China Insurance Regulatory Commission (“CIRC”) announced new rules (Implementing Rules of Provisional Measures on Outbound Investments with